Q32 Bio reports positive 36-week Phase 2a SIGNAL-AA bempikibart data and in SEC filing confirms completion of $200 million public offering
https://finviz.com/stock?t=QTTB&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.